MacroGenics, Inc.
(NASDAQ GS: MGNX)
Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of MacroGenics, Inc. (“MacroGenics” or the “Company”) on behalf of stockholders.
This investigation covers stockholders who purchased or otherwise acquired MacroGenics shares on or before March 7, 2024 and who continue to hold their shares.
ABOUT THE INVESTIGATION
The investigation concerns whether MacroGenics and certain of its directors and/or officers issued materially misleading information and/or failed to disclose material information to the investing public related to the safety data results from the phase 2 study of one the Company’s proprietary products, TAMARACK.
THERE IS NO COST TO YOU
There is no cost to you to join this action. We represent investors on a contingency fee basis. This means that we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees only if we are successful.
If you are interested in joining the action or receiving more information, you may fill out the form below or contact Leah Wihtelin cost free at (516) 693-8926 or by email at lw@rl-legal.com.